Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_assertion type Assertion NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_head.
- NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_assertion description "[PcG protein EZH2 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_provenance.
- NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_assertion evidence source_evidence_literature NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_provenance.
- NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_assertion SIO_000772 17134822 NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_provenance.
- NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_assertion wasDerivedFrom lhgdn-20090331 NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_provenance.
- NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_assertion wasGeneratedBy ECO_0000203 NP166774.RAdWIsEClsW07TC-gS0e50mpj5C7G_WOZbBmpMp0cA8RY130_provenance.